Join Professor Miras live — oral semaglutide for obesity, Wednesday 29 July.

Our July session drew over 400 registrations — due to demand, we’ve added a second live date. Join us for a free evening session with live Q&A.

Hi Droo,

With oral semaglutide newly MHRA-licensed for obesity, prescribers across the UK are asking the same practical questions: who is it right for, how do you titrate it, and what should you monitor? We’ve invited Professor Alexander Miras to answer them live. Our July session drew over 400 registrations — so due to demand, we’ve added a second live date:

Oral Semaglutide for Obesity: What Prescribers Need to Know